Our website uses cookies. They help us understand how customers use our website so we can give you the best experience possible. By continuing to browse this site or choosing to close this message, you give consent for cookies to be used. The cookies are not used for advertising. This applies to visitors from EU.

Samsung’s Bet on Biotechnology Is Test for Heir Apparent

Posted by Biophlox Admin 05/01/2016 0 Comment(s)


In a 740,000-square-foot production facility here, Samsung machines are humming day and night to churn out an unlikely product for the world’s largest maker of smartphones: cancer drugs developed by Bristol-Myers Squibb Co. The Samsung Group's $27.4 billion investment over the past four years in production plants and research laboratories like this..


Click here to read full article


Tags: news research

Author’s Bio


Author’s name: Biophlox Admin

Write a Comment

Google Rating
2 customer reviews